Filing Details
- Accession Number:
- 0001501134-20-000059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-14 18:43:13
- Reporting Period:
- 2020-09-10
- Accepted Time:
- 2020-09-14 18:43:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1640322 | L Robert Nussbaum | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-09-10 | 557 | $33.87 | 231,279 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-10 | 9,391 | $32.97 | 221,888 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-10 | 11,497 | $33.86 | 210,391 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-10 | 1,730 | $34.69 | 208,661 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- Includes an aggregate of 161,973 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- The sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 17, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $32.44 to $33.42 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $33.44 to $34.43 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $34.48 to $34.92 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Billionaire Hedge Funds
